FDC Reports Launches PharmAsia


FDC Reports, the world’s leading information source on the pharma sector has now launched PharmAsiaNews.com, to capture all the exciting pharma news from India, China and Japan. Those have read the “Pink Sheet” will know that FDC Reports is renowned for exceptionally accurate, objective and insightful stories on the pharma sector. With FDC now turning its attention to the exciting pharma developments in India, we (those of us who thirst for this sort of knowledge) are in for a treat….


Read More »
Uncategorized

Tata’s Nano: Patents, Innovation and a Good Laugh!


Note: Those of our readers reading this post as an email in their inbox, I strongly recommend logging onto SpicyIP for the full effect! In November last year, the Economic Times reported that Tata was seeking a patent on its 1 lakh car christened “Nano”. The report stated: “Auto heavyweight Tata Motors is understood to have sought a global patent for the design and technology involved in the much awaited Rs one-lakh car, people close to the development said. Tata,…


Read More »
Innovation Patent

Satyam evam Upaid: Who paid?


I came across this interesting piece in IPKat today, relating to IT giant Satyam and a dispute in the Commercial Court for England and Wales [Satyam Computer Services Ltd v Upaid Systems Ltd [2008] EWHC 31 (Comm)]. This is of relevance not only because it involves an Indian IT company, but also because of implications it might have for other companies in the IT-outsourcing sector generally. This was not an outright IP dispute, e.g. on the patentability of the product…


Read More »
Patent

India gets International Search Authority Status.


The Indian IPR regime that has been making rapid strides in developing its infrastructure has caught world attention. India joins the the elite list of nations to be conferred the ISA status by WIPO. News a couple of weeks late, but nevertheless one that is is an interesting development in the Indian IP arena “The Indian Patent Office has been recognized as the International Searching Authority (ISA) and International Preliminary Examining Authority (IPEA) by the World Intellectual Property Organization (WIPO)…


Read More »
Patent

Roche vs NATCO: India’s First "Doha Style" Compulsory License?


Most of you may have heard of the first “Doha” style compulsory license for export of GSK’s ARV drug, TriAvir from Canada to Rwanda. For a great summary of this case, see this ASIL article. Latha Jishnu of the Business Standard reports that a similar request is being made by Natco Pharma, an Indian generic company, to export Roche’s anti cancer drug, Tarceva (Erlotinib) from India to Nepal. The application is for the export of 30,000 tablets to Nepal and…


Read More »
Uncategorized

Pills, Potions and IPR:Tales from Folk Medicine.


Inspired in content and spirit, by Shamnads’ New Year offerings on Traditional Knowledge and Indigenous medicine with the lush narrative of the Arogyapacha, I add to the ongoing debate and awareness initiatives on the subject….. Allopathy long held as the marquee of the Medicinal systems has close contenders in play. No longer solo on the ramp, Traditional Medicine systems, many of them that predate allopathy have caught world attention. Ayurveda has firmly ensconced a place of pride for itself; inspiring…


Read More »
Copyright Trademark

Time’s up for Scrabulous?


As local news portals trumpet India’s newest homegrown social networking site, www.bigadda.com (see here), another Indian company that has achieved near cult status in the global web 2.0 bandwagon faces closure. Scrabulous, a free online gaming site that allows users to play a version of Scrabble, owned by the Kolkata-based Agarwala brothers, reportedly told Fortune that it had received a legal notice from Hasbro (the makers of Scrabble). Hasbro has allegedly sent a cease-and-desist notice for trademark infringement to the…


Read More »

Roche Patent over AIDS drug in India: Need for Transparency


At a conference in DC, I heard a speaker (from a reputed MNC pharma company), who was comparing the patent systems of the US and China lament:“In China, we can never enforce a patent. In India, our problem is that we can’t even get the patent in the first place” If a recent report by CH Unni of Livemint is to be believed, this may not always hold true. Unni dug through the USPTO database and found that the Roche…


Read More »

Glivec / Gleevec (Imatinib) – Novartis’ many crystalline forms


I posted a note earlier in Spicy IP Tidbits about Novartis’ alpha crystalline Glivec (imatinib) patent which has recently come to light. This application was filed back in 2004, before the changes to Indian patent law, and the subsequent (and ongoing) fight with the IPAB, etc.(Click here for a list of earlier posts about Novartis and Glivec on SpicyIP.) For those who aren’t aware, Novartis has other patents covering imatinib in similar ways. Take for example, WO 2007023182 for Delta…


Read More »
Uncategorized

SpicyIP Events – NIIPM Courses – January 2008


1. The National Institute of Intellectual Property Management (NIIPM) has organized a Training course on patents at its headquarters in Nagpur, India for 16 and 17 January 2008. NIIPM stated that the course has come about because: “it is observed that the patent applications filed by the Indian inventors and companies, are less as compared to foreign applicants. Hence many Indian inventions are not patented and thus remain unprotected and through ignorance of patent law, many inventors jeopardize the chance…


Read More »